# sCD8, as a Novel Biomarker for Pancreatic Cancer

> **NCT05500027** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Serum Biomarker
- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** serum test

## Key facts

- **NCT ID:** NCT05500027
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05500027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05500027, "sCD8, as a Novel Biomarker for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05500027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*